Multiple myeloma (MM) drug resistance (DR) is a multistep transformation process based on a powerful interplay between bone marrow stromal cells and MM cells that allows the latter to escape anti-myeloma therapies. Here we present an overview of the role of the bone marrow microenvironment in both soluble factors mediated drug resistance (SFM-DR) and cell adhesion-mediated drug resistance (CAMDR), focusing on the role of new players, namely miRNAs, exosomes and cancerassociated fibroblasts.

Microenvironment drug resistance in multiple myeloma: Emerging new players

DI MARZO, LUCIA;DESANTIS, VANESSA;SOLIMANDO, ANTONIO GIOVANNI;RUGGIERI, SIMONA;ANNESE, TIZIANA;NICO, Beatrice;FUMARULO, Ruggiero;VACCA, Angelo;
2016-01-01

Abstract

Multiple myeloma (MM) drug resistance (DR) is a multistep transformation process based on a powerful interplay between bone marrow stromal cells and MM cells that allows the latter to escape anti-myeloma therapies. Here we present an overview of the role of the bone marrow microenvironment in both soluble factors mediated drug resistance (SFM-DR) and cell adhesion-mediated drug resistance (CAMDR), focusing on the role of new players, namely miRNAs, exosomes and cancerassociated fibroblasts.
File in questo prodotto:
File Dimensione Formato  
Microenvironment 2016.pdf

accesso aperto

Descrizione: Articolo principale
Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 925.68 kB
Formato Adobe PDF
925.68 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/180493
Citazioni
  • ???jsp.display-item.citation.pmc??? 69
  • Scopus 127
  • ???jsp.display-item.citation.isi??? 123
social impact